Rheumatoid arthritis (RA) may cause inflammation in your eyes, leading to complications such as dry eyes, redness, and floaters, among others. Early treatment may prevent these conditions from ...
Juvenile Idiopathic Arthritis (JIA) is the most common rheumatic disease in children, affecting thousands of young patients across the United States. For some, it comes with a hidden and dangerous ...
Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved expanded indications for YUFLYMA® (adalimumab-aaty) and its unbranded version, to include the treatment of ...
Southwood TR, Woo P . Classification and nomenclature in juvenile arthritis. In: Silman and Symmons classification and assessment of rheumatic diseases. London: Bailliere Tindall, 1995;9:331–5.
GLP-1 RA prescriptions were associated with greater protection against uveitis compared with the cohorts taking metformin and insulin. (HealthDay News) — Glucagon-like peptide 1 receptor agonists (GLP ...
Red eyes can be caused by mild problems like contact overuse and eye strain — or more serious issues like glaucoma or uveitis ...
Please provide your email address to receive an email when new articles are posted on . Increased risk for blindness was associated with male sex, Black race and Medicaid insurance among patients with ...
Around 5% of US Population Diagnosed With Autoimmune Disease A new analysis tool estimated that over 15 million individuals in the United States were affected with autoimmune diseases in 2022, with ...
Juvenile idiopathic arthritis and rheumatoid arthritis are both inflammatory diseases that affect the joints, but they’re separate conditions with unique long-term outlooks. The most common type of ...
YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback